DHDavid N. Herrmann

David N. Herrmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David N. Herrmann has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Is folate deficiency a common cause of distal symmetric polyneuropathy in Zambian clinics?

    by Michelle Kvalsund, Violet Kayamba, Paul Kelly, Gretchen L. Birbeck, Cleopatra Mwansa-Thurman, Ingrid Nyeggen Sommer, Yvonne Lamers, Joseph Gardiner, David N. Herrmann


  • Charcot-Marie-Tooth Disease and Pregnancy

    by Peter D. Creigh, David N. Herrmann

    Charcot-Marie-Tooth neuropathies (CMT) represent the most common hereditary neuropathies and can affect men and women from infancy to adulthood. There are no effective or FDA approved pharmacologic treatments aimed at disease modification for any form of CMT, so the primary focus of clinical care is on symptomatic treatment, maintaining functionality, and limiting secondary injury. CMT does not in general appear to affect a woman’s ability to carry a pregnancy. However, having CMT does increase the risk of delivery related complications (operative delivery, fetal presentation anomalies and postpartum bleeding) and exacerbation of neurologic symptoms during pregnancy is possible. Therefore, understanding the risks and planning appropriately are crucial for all women with CMT considering pregnancy and their health care providers. Overall, with the appropriate medical care, most women with CMT who choose to become pregnant will have an uncomplicated pregnancy and deliver a healthy infant.


  • In-vivo reflectance confocal microscopy of Meissner's corpuscles in diabetic distal symmetric polyneuropathy

    by Peter D. Creigh, Michael P. McDermott, Janet E. Sowden, Michele Ferguson, David N. Herrmann


  • Approach to Peripheral Nerve Disorders

    by David N. Herrmann, Eric L. Logigian


  • HIV neuropathy: an in vivo confocal microscopic study

    by Jorge L. Almodovar, Giovanni Schifitto, Michael P. McDermott, Michele Ferguson, David N. Herrmann

    Several approaches exist for quantitative assessment of human immunodeficiency virus (HIV)-associated distal sensory polyneuropathy (DSP). While useful, each has some limitations. This study evaluated non-invasive, in vivo reflectance confocal microscopy (RCM) of Meissner corpuscles (MCs) as a measure of HIV-DSP. Forty-eight adults (29 HIV-infected, 19 controls) underwent RCM of MC density (MCs/mm2) at the arch, fingertip, and thenar eminence (TE); ankle skin biopsy to measure epidermal nerve fiber density (ENFD); electrophysiologic studies; and tactile, vibration, and thermal threshold testing. HIV+ subjects were clinically categorized as having DSP signs or no signs. MC densities were lower in HIV+ subjects with DSP signs than in controls (arch, p = 0.0003; fingertip, p < 0.0001; TE, p = 0.0002). Tactile thresholds in the TE and foot were worse in HIV-DSP than in controls, but in this mild DSP cohort, sural amplitudes, ENFD, and vibration and thermal thresholds did not differ significantly from controls. Fingertip MC densities and tactile thresholds at the foot were also lower in HIV+ subjects without DSP signs than in controls. Other sensory measures were not significantly different in HIV+ subjects without DSP signs than in controls. MC density correlated inversely with tactile thresholds at each imaging location. The results suggest that RCM of MC density complements existing sensory DSP measures and discriminates mild HIV-DSP from controls at a stage when sural amplitudes do not. Further studies are required to determine whether RCM of MC density can establish quantitative changes in DSP, in response to treatment or disease progression.


  • In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A

    by Jorge L. Almodovar, Michele Ferguson, Michael P. McDermott, Richard A. Lewis, Michael E. Shy, David N. Herrmann

    Reliable, valid, and responsive outcomes for different aspects of Charcot-Marie-Tooth (CMT) neuropathy have become increasingly important in an emerging era of therapy development. Measures of the sensory component of CMT in particular are limited. One novel approach with potential applicability to CMT is non-invasive in vivo reflectance confocal microscopy (RCM) of Meissner corpuscles (MCs). In this prospective study, we evaluated MC densities using RCM, and touch-pressure and vibration sensation thresholds in a cohort of Charcot-Marie-Tooth type 1A (CMT1A) subjects with comparison to healthy controls. MC density was lower in CMT1A subjects than in controls at the fingertip (digit V) (2.59 ± 2.73 MCs/mm2 vs. 6.77 ± 3.68 MCs/mm2, p = 0.001), but not more proximally at the thenar eminence. Touch-pressure thresholds were higher in CMT1A than in controls at digit V (p = 0.002) and at the thenar eminence (p = 0.0001). Vibration thresholds in CMT1A at digit V were also higher than in controls (p = 0.0001). A lower MC density at digit V was associated with greater global CMT severity as reflected by the Charcot-Marie-Tooth neuropathy score (CMTNS) (r = −0.76, p = 0.004) and the Neuropathy impairment score (NIS) (r = −0.73, p = 0.007). Similarly, worse touch-pressure thresholds at the fingertip (digit V) were associated with more severe CMT1A on the CMTNS (r = 0.71, p = 0.009) and NIS (r = 0.70, p = 0.011). Vibration thresholds at digit V were not associated with either the CMTNS (r = 0.11, p = 0.74) or NIS (r = 0.21, p = 0.52). Non-invasive in vivo RCM of MC density at the hand and the evaluation of touch-pressure thresholds show promise as measures of sensory structure and function in CMT1A.


  • Broadening the spectrum of controls for skin biopsy in painful neuropathies

    by David N. Herrmann, Alec B. O'COnnor, Steven R. Schwid, Yuwei DA, Andrew D. Goodman, Jennifer Rafferty, Suzanne Donahue, Robert H. Dworkin

    Epidermal nerve fiber density (ENFD) is useful in the evaluation of small‐fiber neuropathies (SFSNs). A recent evidence‐based review highlighted the need to broaden the spectrum of ENFD controls to include lower limb pain states other than polyneuropathy. We studied epidermal innervation in multiple sclerosis (MS) and distal lower limb burning pain (DLLBP). Distal‐leg ENFD/morphology in MS DLLBP patients did not differ significantly from that of healthy controls. This study extends the range of ENFD controls and further supports use of ENFD assessment in SFSN. Muscle Nerve, 2010


  • Is the bedside timed vibration test reliable?

    by Stephan A. Botez, George Liu, Eric Logigian, David N. Herrmann

    The timed vibration test (TVT) is an easy-to-perform bedside sensory test; however, its reliability is not well established at sites commonly used for clinical testing. We evaluated intra- and interrater reliability of the TVT in a healthy control cohort of 25 adult volunteers and assessed the influence of neurologic training on TVT. Intrarater [intraclass correlation coefficient (ICC) range 0.79–0.92] and interrater (ICC range 0.0.82–0.95) reliability of TVT was high at different sites, which suggests that TVT is a reliable bedside examination when performed using a standardized protocol. Muscle Nerve 39: 221–223, 2009


  • Noninvasive and minimally invasive detection and monitoring of peripheral neuropathies

    by David N Herrmann

    Peripheral neuropathies are diverse and require a multidimensional approach for detection and monitoring in a clinical and research setting. This review describes non- and minimally-invasive measures of distal predominantly sensory polyneuropathy (DSP), the most common form of neuropathy. A combination of clinical and electrophysiologic assessment with nerve-conduction studies (NCSs) suffices for the detection and characterization of most DSPs. NCS are insensitive to variants of DSP that predominantly affect small diameter sensory nerve fibers (SFNs) and cutaneous nerve terminals that subserve pain and thermal sensation. Skin biopsy with assessment of epidermal nerve fiber density permits objective detection and monitoring of SFNs. Conventional clinical and NCS measures have limitations as outcomes in experimental therapeutics in DSP. For clinical trials, biopsy evaluation of epidermal innervation and emerging noninvasive imaging approaches (in vivo confocal microscopy of corneal innervation and of Meissner corpuscles in the skin) hold promise as surrogate markers that are complementary to traditional DSP measures.